1st Counsel – Lifestyle
Author:
China Medical System Holdings Ltd.
CMS(867.HK/8A8.SG): New Drug for Renal Anaemia Desidustat Tablets Approved in China
March 13, 2026
CMS(867.HK/8A8.SG):Ruxolitinib Phosphate Cream (Lumirix®) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
March 13, 2026
CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
March 5, 2026